A Phase 2, Outcomes Assessor-Masked, Multicentre, Randomised Study to Evaluate the Safety and Efficacy of Two Doses of Gt005 Administered as A Single Subretinal Injection in Subjects with Geographic Atrophy Secondary to Age-Related Macular Degenerati